165 results
Page 2 of 9
6-K
EX-99
arupitdfd83hqji8
16 Mar 22
BioLineRx Reports Fourth Quarter 2021 Financial Results
7:11am
6-K
EX-99
gh3yri3oeltz
3 Mar 22
BioLineRx Announces Additional Positive Results from
7:10am
6-K
EX-99
q6zo155v 3wv8
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-1
c1gir2 0vkwxg
4 Nov 21
BioLineRx Announces an Oral Presentation and Three
10:15am
424B5
05lrp4lcdozf r2
3 Sep 21
Prospectus supplement for primary offering
4:29pm
6-K
EX-99
syxc3w
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
zlqe0qqfiue6 4b87t65
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
424B5
1o9tz5b5zn33
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
w7g2f87850io
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
vl7tdidyu6m76
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
tjknfvbl5yuzzf
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
wrm4jm9owhbc3 7g
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
37pt9
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
6dsbp2
25 Sep 20
Prospectus supplement for primary offering
4:30pm
POS AM
tx3e8395xb7 mjnpwl3k
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
6-K
EX-99
4gc5wgty
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B3
wlxi870e48
2 Jul 20
Prospectus supplement
4:28pm
F-1
5mr047v1nda bhr
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
qogch47lz7qm 3it
3 Jun 20
Prospectus supplement for primary offering
8:33am